chr5-14143769-C-T
Variant summary
Our verdict is Benign. Variant got -10 ACMG points: 1P and 11B. PP2BP4_ModerateBP6BS1BS2
The NM_007118.4(TRIO):c.44C>T(p.Ser15Phe) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000915 in 1,005,088 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 13/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Consequence
NM_007118.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -10 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
TRIO | NM_007118.4 | c.44C>T | p.Ser15Phe | missense_variant | 1/57 | ENST00000344204.9 | NP_009049.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
TRIO | ENST00000344204.9 | c.44C>T | p.Ser15Phe | missense_variant | 1/57 | 1 | NM_007118.4 | ENSP00000339299 | P1 | |
TRIO | ENST00000698541.1 | c.44C>T | p.Ser15Phe | missense_variant | 1/37 | ENSP00000513786 | ||||
TRIO | ENST00000502816.1 | n.68C>T | non_coding_transcript_exon_variant | 1/5 | 2 | |||||
TRIO | ENST00000505971.5 | n.68C>T | non_coding_transcript_exon_variant | 1/4 | 3 |
Frequencies
GnomAD3 genomes AF: 0.000410 AC: 60AN: 146342Hom.: 0 Cov.: 31
GnomAD4 exome AF: 0.0000373 AC: 32AN: 858746Hom.: 0 Cov.: 29 AF XY: 0.0000251 AC XY: 10AN XY: 398954
GnomAD4 genome AF: 0.000410 AC: 60AN: 146342Hom.: 0 Cov.: 31 AF XY: 0.000408 AC XY: 29AN XY: 71150
ClinVar
Submissions by phenotype
not provided Uncertain:1Benign:1
Uncertain significance, criteria provided, single submitter | clinical testing | Revvity Omics, Revvity | Jan 28, 2021 | - - |
Benign, criteria provided, single submitter | clinical testing | GeneDx | Mar 20, 2020 | - - |
Inborn genetic diseases Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Ambry Genetics | Oct 01, 2021 | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at